Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic Cancer

Clinical trial NCT02124317 · UNKNOWN

Trial details

NCT number: NCT02124317
Sponsor: Chinese PLA General Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Pancreatic Cancer

Start date: 2014-04-01
Primary completion: 2016-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.